Patents
Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
02/2010
02/25/2010US20100047187 Methods of treating parkinson's disease using halogenated volatile compounds
02/25/2010US20100043788 Devices and methods for minimizing and treating high-altitude sickness
02/25/2010CA2734788A1 Systems and devices for generating nitric oxide
02/24/2010EP2156820A1 Skin whitening agent
02/24/2010EP2155215A1 A gold nanoparticle based protease imaging probes and use thereof
02/24/2010EP2155214A1 Method for pain control
02/24/2010EP2154961A1 Anti-microbial composition and method for making and using same
02/24/2010EP1869185B1 Conjugate comprising p21 protein for the treatment of cancer
02/24/2010EP1689381B1 Pharmaceutical composition comprising i.a. vitamin c, magnesium, green tea extract for retarding cardiovascular diseases (smc proliferation)
02/24/2010EP1294422B1 Medical System for Reducing Vascular Occlusions
02/24/2010CN201409610Y Medicine toothbrush
02/24/2010CN101657205A Agent for preventing bleeding from cerebral cortical vein
02/24/2010CN101653458A Microelement composition for improving reproduction performance of breeding pigs
02/24/2010CN101653457A Microelement composition for promoting growth of suckling pigs
02/24/2010CN101653456A Microelement composition for promoting growth of growing-finishing pigs
02/24/2010CN101653455A Microelement composition for improving production performance of layer chicken
02/24/2010CN101653454A Medicament capable of dehydrating and withering pathological tissues
02/24/2010CN101653453A New application of montmorillonite
02/24/2010CN101653452A Vermiculite extracting solution and application thereof
02/24/2010CN100591331C Combination chemotherapy compositions
02/23/2010US7666829 Compositions for elastogenesis and connective tissue treatment
02/23/2010US7666638 Preparing selenium-enriched biomass having Se-methionine content of at least 11.39 ng/mgd.w. by culturing microorganisms selected from Lactobacillus reuteri DSM16143, Lactobacillus ferintoshensis DSM16144 and Lactobacillus buchneri/parabuchneri DSM16341 in culture medium comprising selenium salt
02/23/2010US7666453 Mineral oil, zinc oxide, gum karaya powder, tea tree oil, aloe vera and a fungicide amphotericin B, butoconazole, clotrimazole, fluconazole, miconazole, ketoconazole, flucytosine, terbinafine, itraconazole, and terconazole; diaper rash; psoriasis, eczema, ichthyosis, pruritus, dryness, dermatitis
02/18/2010WO2010019164A1 Optical blurring pigment composition suitable for use in cosmetics
02/18/2010WO2010018418A1 Formulation based on micronized clinoptilolite as therapeutic agent providing highly bioavailable silicon
02/18/2010WO2010018278A2 Composition comprising crystallisation inhibitory substances
02/18/2010WO2010017633A1 Use of nitric oxide
02/18/2010WO2010017623A1 Antimicrobial silver solutions
02/18/2010WO2009154819A3 Treatment of inflammatory conditions and diseases with metal-thiols
02/18/2010WO2009140341A3 Atorvastatin compositions
02/18/2010WO2009139972A3 Site specific fluorescence marking and contrast marker for same
02/18/2010WO2009120697A3 Method and compositions for treatment of cancer
02/18/2010WO2008121006A8 Selenium administration
02/18/2010US20100040703 Use of nitric oxide
02/18/2010US20100040700 Kit for promoting hair growth
02/18/2010US20100040686 Biomaterial
02/18/2010US20100040628 Indoprofen derivatives for promoting bone growth
02/18/2010US20100040603 Methods for promoting protection and regeneration of bone marrow using cxcl9 and anti-cxcl9 antibodies
02/18/2010US20100040599 Therapeutic agent for rheumatoid arthritis
02/18/2010US20100040565 Active delivery systems formulations
02/18/2010CA2733509A1 Antimicrobial silver solutions
02/18/2010CA2732881A1 Composition that comprises crystallisation inhibitory substances
02/18/2010CA2709097A1 Optical blurring pigment composition suitable for use in cosmetics
02/17/2010EP2152321A1 Water treatment containing dbnpa for use in sanitizing recreational water
02/17/2010EP2152278A2 Enhancement of the calcium sensing receptor
02/17/2010EP2152239A1 Stable oxaliplatin composition for parenteral administration
02/17/2010CN101647810A Liquid calcium soft capsule
02/17/2010CN101647809A Traditional Chinese medicine powder for treating toothache due to fire-evil
02/16/2010US7662373 Comprising an emulsifier, a bowel relaxant and one or more chelating agents to absorb and mechanically agitate non-digested fats; decreased side effects
02/16/2010US7661424 Method of use of gas mixtures to achieve nitrogen washout from the body and mitochondria of the heart
02/16/2010CA2430001C Light stabilized antimicrobial materials
02/16/2010CA2421721C Therapeutic topical solution for skin and associated methods of use
02/11/2010WO2010017443A2 Anti-beta-2-microglobulin agents and the use thereof
02/11/2010WO2010016581A1 Ultrasonic cancer therapy accelerator
02/11/2010WO2010015697A1 Anti-allergen combinations of calcium and lanthanum salts
02/11/2010US20100034902 Method for the diagnosis and treatment of salt sensitivity and related conditions
02/11/2010US20100034901 Animal feed compositions
02/11/2010US20100034899 Use of one or more of the elements from the group yttrium, neodymium and zirconium, and pharmaceutical compositions which contain those elements
02/11/2010US20100034898 Cartilage simulating bio-material composition and method
02/11/2010US20100034893 Particulate uv protection agent
02/11/2010US20100034882 Silver-containing compositions, devices and methods for making
02/11/2010US20100034874 Liposome encapsulating ammine-platinum complex at high concentration, and method for production of the liposome
02/11/2010US20100034873 Transdermal ricinoleic acid compositions
02/11/2010US20100034865 Osteoinductive calcium phosphates
02/11/2010US20100034813 Substituted pyrazole and triazole compounds as ksp inhibitors
02/11/2010CA2730778A1 Anti-allergen combinations of calcium and lanthanum salts
02/10/2010EP2151242A1 Use of oxygen for treatment of illnesses of the mucous membrane of the intestinal channel
02/10/2010EP1499331B1 Salt solution for colon cleansing
02/10/2010CN101642468A Pharmaceutical composition for lowering blood glucose and blood lipids
02/10/2010CN100588406C Medicament for treating chronic renal failure and production method
02/09/2010USRE41109 Includes sulfuric acid combined with distilled water and ammonium sulfate under at least 15 psi pressure in a pressurized container, heated to approximately 800 degrees F. or more for at least 3 hours, stabilized with 10 percent of original mixture; for preserving food, and for treatment of melanoma
02/09/2010US7659257 Medicament for treating lung cancer
02/09/2010US7658952 Dialysis solutions containing pyrophosphates
02/09/2010US7658940 Mixing kit components containing a setting fluid, dry calcium carbonate, oxide or hydroxide, dry phosphoric acid and bone particles, making a flowable, moldable mixture for orthopedics or dentistry
02/09/2010US7658914 first container containing a dry formulation of polyoxyethylene glycol , ascorbic acid and sodium sulfate, calcium sulfate and sodium chloride, potassium chloride, second container containing dry ascorbic acid or sodium or potassium salt; also contains flavor, sweetener; for colonoscopy preperation
02/09/2010CA2407112C Method for treating cancer, visualizing cell structures, and isolating organelles using organelle crystallizing agents
02/09/2010CA2286614C Plant extracts for the treatment of increased bone resorption
02/04/2010WO2010014818A1 Methods of treating an infection with nitric oxide
02/04/2010WO2010013785A1 Adsorbent, cleansing agent, remedy for kidney disease and functional food
02/04/2010WO2010013129A1 Coccidiocide combination for veterinary use
02/04/2010WO2010012720A1 Compositions for the prophylaxis and treatment of dermatological/mucosal diseases, and uses thereof
02/04/2010WO2009151496A9 Induction of proliferation, effector molecule expression, and cytolytic capacity of hiv-specific cd8+ t cells
02/04/2010WO2009129208A3 Compositions and methods of inducing endoplasmic reticulum stress reponse
02/04/2010US20100028461 Gamma-butyrolactone compound and pharmaceutical composition thereof
02/04/2010US20100028460 Improvements in relation to cancer therapy
02/04/2010US20100028459 Nutritional supplement composition for treatment of ocular diseases
02/04/2010US20100028458 Mild composition for skin disinfection
02/04/2010US20100028457 Agent for prevention or treatment of blood glucose level elevation
02/04/2010US20100028456 Broad-spectrum antiviral composition with excellent preservation stabilty
02/04/2010US20100028443 Compositions and methods for treating inflammation
02/04/2010US20100028441 Compositions and methods for treating multiple sclerosis
02/04/2010US20100028436 Polymer matrix, uses thereof and a method of manufacturing the same
02/04/2010US20100028413 Skin treatment strip
02/04/2010US20100028395 Compositions containing n-acetylglucosamine for use in dermo-cosmetology and aesthetic medicine
02/04/2010US20100028338 Gimatecan (7-t-butoxyiminomethylcamptothecin) and chemotherapeutic agents
02/04/2010US20100028318 Agent for relief or prevention of xerostomia
02/04/2010DE20321786U1 Kombinationspräparat aus oralem Kontrazeptivum und Calcium/Vitamin D Combination preparation of oral contraceptive and calcium / vitamin D
02/04/2010CA2732340A1 Compositions for the prophylaxis and treatment of dermatological/mucosal diseases, and uses thereof
02/03/2010EP2149376A1 Body-temperature lowering depressant
02/03/2010EP2149375A1 Compositions for the treatment of dermatological diseases, and uses thereof